6S2I
Anti-tumor antibody 14F7-derived scFv in complex with NeuGc Gm3
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | ESRF BEAMLINE MASSIF-3 |
| Synchrotron site | ESRF |
| Beamline | MASSIF-3 |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2017-05-15 |
| Detector | DECTRIS EIGER X 4M |
| Wavelength(s) | 0.9677 |
| Spacegroup name | P 1 21 1 |
| Unit cell lengths | 62.880, 113.690, 66.950 |
| Unit cell angles | 90.00, 91.24, 90.00 |
Refinement procedure
| Resolution | 62.865 - 2.285 |
| R-factor | 0.2237 |
| Rwork | 0.222 |
| R-free | 0.25460 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 6ffj |
| RMSD bond length | 0.002 |
| RMSD bond angle | 0.542 |
| Data reduction software | XDS |
| Data scaling software | XSCALE |
| Phasing software | PHENIX |
| Refinement software | PHENIX ((1.13_2998: ???)) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 62.900 | 2.325 |
| High resolution limit [Å] | 2.285 | 2.285 |
| Rmerge | 0.097 | 0.697 |
| Rmeas | 0.111 | 0.795 |
| Rpim | 0.053 | 0.379 |
| Number of reflections | 42116 | 2141 |
| <I/σ(I)> | 9.03 | 2.1 |
| Completeness [%] | 98.8 | 99.1 |
| Redundancy | 4.2 | 4.4 |
| CC(1/2) | 0.980 | 0.813 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 8.5 | 298 | 12.5 % w/v PEG 1000, 12.5 % w/v PEG 3350, 12.5 % v/v MPD, 0.02 M 1,6-hexandiol, 0.02 M 1-butanol, 0.02 M (RS)-1,2-propanediol, 0.02 M 2-propanol, 0.02 M 1,4-butanediol, 0.02 M 1,3-propanediol, 0.1 M bicine/tris base pH 8.5 |






